This inventor holds 3 USPTO granted patents. Top assignees: Panacea Pharmaceuticals, Inc., Nymox Corporation. Active years: 2002-2009.
Company Filing History:
Years Active: 2002-2009
Title: The Innovations of Benjamin Wolozin
Introduction
Benjamin Wolozin is a notable inventor based in Hinsdale, IL, who has made significant contributions to the field of neurodegenerative disease research. He holds three patents that focus on innovative methods for treating diseases associated with alpha-synuclein aggregation, particularly Parkinson's Disease. His work is pivotal in the ongoing search for effective treatments for these debilitating conditions.
Latest Patents
Wolozin's latest patents include groundbreaking inventions aimed at addressing alpha-synuclein diseases. One of his patents, titled "Isolated peptides to treat alpha-synuclein diseases," relates to drug screening methods and strategies for preventing neural tissue damage caused by alpha-synuclein aggregation. This invention is particularly useful in designing inhibitors for Lewy body diseases and other synucleinopathies. Another significant patent, "Compositions for inhibiting the aggregation pathway of alpha-synuclein," provides methods for determining the aggregation of alpha-synuclein, which is a hallmark of Lewy body diseases such as Parkinson's disease. This patent also discloses inhibitors of the aggregation, including magnesium and alpha-synuclein binding peptides, which are beneficial in treating Lewy body diseases.
Career Highlights
Throughout his career, Wolozin has worked with various companies, including Panacea Pharmaceuticals, Inc. and Nymox Corporation. His experience in these organizations has allowed him to develop and refine his innovative approaches to treating neurodegenerative diseases. His contributions have been instrumental in advancing the understanding and treatment of conditions related to alpha-synuclein.
Collaborations
Wolozin has collaborated with notable colleagues in his field, including Natalie Ostretova-Golts and Michael Lebowitz. These collaborations have further enriched his research and have contributed to the development of effective treatments for neurodegenerative diseases.
Conclusion
Benjamin Wolozin's work in the field of neurodegenerative diseases showcases his dedication to innovation and research. His patents and collaborations highlight the importance of continued exploration in the treatment of conditions like Parkinson's Disease. His contributions are paving the way for future advancements in medical science.